Lacosamide Tablet, Film Coated
Product Images NDC 68462-681

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 68462-681). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc. Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of lacosamide, depicted as a 2D molecular diagram showing atoms and bonds characteristic of the compound.*

FDA Label Image

Figure1 (Figure1)

A bar chart showing median percent seizure reduction from baseline in three clinical studies comparing placebo versus different doses of lacosamide. The graph displays data from Study 2, Study 3, and Study 4, with lacosamide doses ranging from 200 mg to 600 mg per day. Statistically significant improvements versus placebo are indicated by asterisks.*

FDA Label Image

Figure2 (Figure2)

A cumulative responder rate curve graph showing improvement and worsening responder rates by percent of patients for placebo and lacosamide doses of 200 mg/day, 400 mg/day, and 600 mg/day. The graph plots responder rate (equal to or greater improvement vs worsening) on the vertical axis and percent of patients on the horizontal axis, comparing therapeutic response across these groups.*

FDA Label Image

Figure3 (Figure3)

A Kaplan-Meier survival curve comparing the proportion of patients over time (days) between lacosamide and placebo groups. The graph shows two lines representing patients receiving lacosamide (dashed line) and placebo (solid line), with the number of patients at risk displayed below the x-axis. Statistical values including p-value, hazard ratio, and confidence interval are noted on the graph.*

FDA Label Image

Glenmarklogo1 (Glenmarklogo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Label50mg (Label50mg)

Label for Lacosamide Tablets, USP 50 mg oral film-coated tablets by Glenmark Pharmaceuticals Inc. USA. The carton contains 60 tablets with a National Drug Code (NDC) 68462-678-60. It includes usage information regarding medication guides and storage instructions, along with contact details and website for Glenmark Pharmaceuticals.*

FDA Label Image

Label100mg (Label100mg)

Lacosamide Tablets USP 100 mg film-coated tablets label from Glenmark Pharmaceuticals Inc. USA. The package contains 60 tablets with NDC 68462-679-60. It instructs pharmacists to dispense the Medication Guide separately to each patient and provides storage instructions between 20°C to 30°C (68°F to 86°F). Contact information and a website for medication guides are included.*

FDA Label Image

Label150mg (Label150mg)

Label for Lacosamide Tablets, USP 150 mg film-coated tablets by Glenmark Pharmaceuticals Inc. USA. The label specifies a pack of 60 tablets, prescription only, with storage instructions and a barcode. It includes a notice to dispense the Medication Guide to each patient and contact information for Glenmark Pharmaceuticals.*

FDA Label Image

Label200mg (Label200mg)

Lacosamide Tablets, USP 200 mg film-coated oral tablets, labeled for 60 count. The packaging label shows the product name, strength, dosage form, and is marked Rx only. It is manufactured and distributed by Glenmark Pharmaceuticals Inc. USA, with storage instructions and contact information included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.